1Yang E, Ahes T, Anupindi SA. Early mycoplasnm pneumoniae infection presenting as multiple puhnonary masses: an unusual presentation in a child[J]. Pediatr Radiol, 2008, 38(4): 477- 480.
2Gaillat J, Flahauh A, Debarbeyrae B, et al. Community epi- demiolog of chlamydia and mycoplasma pneumoniae in LRTI in France over 29 months[J]. Eur J Epidemiol, 2005, 20(7): 643-651.
3Nagalingam NA, Adesiyun AA, Swanston WH, et al. Prevalence of myeoplasma pneumoniae and chlamydia pneumoniae in pneumonia patients in four major hospitals in Trinidad[J]. New Microbiol, 2004, 27(4): 345-351.
9Shahzad W, Ajuwape AT, Roseabusch RF. Global suppression of mitogen-activated ovine peripheral blood mononuclear ceils by surface protein activity from Mycoplasma ovipneumoniae [J]. Vet Immunol Immunopathol, 2010, 136(1-2) : 116-121.
5Wakes KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen[J ]. Clin Microbiol Rev, 2004, 17 (4):697- 728.
6Stelmach M, Podsiadlowicz - Borzeeka T, Grzelewski P, et al. Humoral and cellular immunity in children with mycoplasma pneumoniae infection:a 1 -year prospective study[J]. Clin Vaccine Immunol, 2005, 12(10) : 1 246 - 1 250.
7Waites KB, Atkinson TP. The role of Mycoplasma in upper respiratory infections[ J]. Curr Infect Dis Rep,2009,11 (3) : 198 - 206.
8Defilippi A,Silvestri M,Tacchella A ,et al. Epidemiology and clinical features of mycoplasma pneumoniae infection in children[ J ]. Respir Med, 2008, 102(12) :1762 - 1768.
